drugset / Trial / NCT00682461

Oral Tolerability Of Two Nicotine Dosage Forms

NCT00682461

Phase 1 Completed 200 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to evaluate the oral tolerability of a nicotine prototype

Timeline

Start
2007-09
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Oral

Indications

No indication recorded.